- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05056311
Engaging Families to Improve the Care of Patients With Hypospadias
Reconstructive surgery is advocated for most children with hypospadias, a condition in which the pee hold is not in the correct place on the penis, to prevent potentially serious cosmetic and functional problems. Parents faced with a decision about hypospadias repair encounter an irreversible choice with potentially lifelong consequences. Recent studies have identified decisional conflict (DC) and decisional regret (DR) as a significant problem for parents. Several recent guidelines on complex urologic topics suggest that shared decision-making (SDM) is the optimal approach.
A pilot test of a decision aid website by parents potentially facing this decision will be conducted to measure pre- and post-outcomes, in order to develop a fuller understanding of how urologists can effectively provide parents with optimal decision support. Parents will answer questions via phone up to four time points, twice before (T1 and T2) and twice after seeing a urologist for a hypospadias referral (T3 and T4). If the urologist diagnoses hypospadias but recommends no surgery, the final data collection point will be three months after the urology visit. If the urologist recommends repair surgery, the final data collection point will be six months after surgery.
Study Overview
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Indiana
-
Indianapolis, Indiana, United States, 46202
- Indiana University
-
-
North Carolina
-
Chapel Hill, North Carolina, United States, 27599
- UNC
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- parents 18 years of age and older of sons with hypospadias, or a tentative hypospadias diagnosis, and/or referral to a urologist for hypospadias
- patient newborn up to age 5 years
- parent able to consent and do interview in English
- parent access to a reliable internet and smart phone, tablet, or computer to view the website
- child/patient scheduled to see a urologist, but must not have yet seen the urologist at the time of enrollment
- parent aware that there is an issue with child's pee hole
- parent planning to attend urology appointment
Exclusion Criteria:
- As target enrollment groups are filled, parents may be excluded in order to achieve a balanced sample, e.g. exclusion of mothers/female caregivers.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Parent Utilization of Decision Aid Website
All enrolled parents will view the decision aid website for as long and as frequently as they wish before the initial visit to the urologist.
|
The (private) decision aid website contains information in text, graphic, and video form about hypospadias and considerations for choosing surgery and no surgery.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Percent of Eligible Parents Screened (Feasibility)
Time Frame: Baseline (T1)
|
Recruitment is defined as the number of potential participants who are eligible divided by the total number screened multiplied by 100.
|
Baseline (T1)
|
|
Percent of Eligible Parents Enrolled (Feasibility)
Time Frame: Baseline (T1)
|
The number of parents enrolled divided by the total number of parents who were eligible multiplied by 100.
|
Baseline (T1)
|
|
Decision Aid Acceptability by Categories of Information, Length, Clarity, and Balance (Acceptability)
Time Frame: Pre-consultation, 1 week after baseline (T2)
|
Acceptability of a decision aid refers to ratings regarding the comprehensibility of components of a decision aid, its length, clarity, amount of information, and balance in presentation of information about options.
The tool has 4 questions with answers on a Likert scale ranging from 1-5 (length, amount of information, and balance) and 1-4 (clarity).
A response of 3 is ideal for information, length, and balance and a response of 1 is ideal for clarity.
|
Pre-consultation, 1 week after baseline (T2)
|
|
Percentage of Parents Retained in the Study (Feasibility)
Time Frame: T1 to T4, a total of approximately 6 months
|
Number of parents who completed the study divided by the number of eligible parents enrolled who completed the study multiplied by 100.
|
T1 to T4, a total of approximately 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mean Decisional Conflict Scale (DCS) Score at T1 and T2
Time Frame: Baseline (T1), Pre-consultation, 1 week after baseline (T2)
|
The Decisional Conflict Scale (DCS) measures personal perceptions of uncertainty in choosing options, modifiable factors contributing to uncertainty such as feeling uninformed, unclear about personal values and unsupported in decision making, and effective decision making (in full version) such as feeling the choice is informed, values-based, likely to be implemented and expressing satisfaction with the choice.
This study utilizes the full version, a Likert-type scale consisting of 16 questions and answer options of strongly agree to strongly disagree.
Total scores range from 0-100, a higher score means more decisional conflict.
|
Baseline (T1), Pre-consultation, 1 week after baseline (T2)
|
|
Mean Decisional Conflict Scale (DCS) Score at T2 and T3
Time Frame: Pre-consultation, 1 week after baseline (T2), Initial post-consultation, within 48 hours of urology visit (T3)
|
The Decisional Conflict Scale (DCS) measures personal perceptions of uncertainty in choosing options, modifiable factors contributing to uncertainty such as feeling uninformed, unclear about personal values and unsupported in decision making, and effective decision making (in full version) such as feeling the choice is informed, values-based, likely to be implemented and expressing satisfaction with the choice.
This study utilizes the full version, a Likert-type scale consisting of 16 questions and answer options of strongly agree to strongly disagree.
Total scores range from 0-100, a higher score means more decisional conflict.
Time frame revised to address original entry error.
|
Pre-consultation, 1 week after baseline (T2), Initial post-consultation, within 48 hours of urology visit (T3)
|
|
Mean Decision-Specific Knowledge Scores
Time Frame: Baseline (T1), Pre-consultation, 1 week after baseline (T2)
|
Decision-Specific Knowledge is a six-question tool with multiple choice question and answer options created by the investigator to measure pre/post knowledge of hypospadias and repair surgery.
Total scores range from 0-100% with a higher score indicating more correct answers.
|
Baseline (T1), Pre-consultation, 1 week after baseline (T2)
|
|
Mean Decisional Regret Scale Score
Time Frame: 3-month post-consultation (T4)
|
The Decision Regret Scale measures distress or remorse after a decision.
Brehaut's (2003) 5-item scale has scores ranging from 0-100, where 100 indicates maximal regret, and 0 indicates no regret.
|
3-month post-consultation (T4)
|
|
Hypospadias Treatment Preference by Category at T1 and T2
Time Frame: Baseline (T1), Pre-consultation, 1 week after baseline (T2)
|
This is a single question created by the investigator asking "Do you intend for your son to have hypospadias surgery?" with yes/no/unsure answer options to measure a change in response, or not, after viewing the decision aid website.
|
Baseline (T1), Pre-consultation, 1 week after baseline (T2)
|
|
Hypospadias Treatment Preference by Category at T2 and T3
Time Frame: Pre-consultation, 1 week after baseline (T2), Initial post-consultation, within 48 hours of urology visit (T3)
|
This is a single question created by the investigator asking "Do you intend for your son to have hypospadias surgery?" with yes/no/unsure answer options to measure a change in response, or not, after viewing the decision aid website.
|
Pre-consultation, 1 week after baseline (T2), Initial post-consultation, within 48 hours of urology visit (T3)
|
|
Awareness of Decision by Category at T1 and T2
Time Frame: Baseline (T1), Pre-consultation, 1 week after baseline (T2)
|
This is a single question created by the investigator asking "Is there a decision to make about whether your son should have surgery for his hypospadias?"
with yes/no/unsure answer options to measure a change in awareness of decision, or not, after viewing the decision aid website.
|
Baseline (T1), Pre-consultation, 1 week after baseline (T2)
|
|
Awareness of Decision by Category at T2 and T3
Time Frame: Pre-consultation, 1 week after baseline (T2), Initial post-consultation, within 48 hours of urology visit (T3)
|
This is a single question created by the investigator asking "Is there a decision to make about whether your son should have surgery for his hypospadias?"
with yes/no/unsure answer options to measure a change in awareness of decision, or not, after viewing the decision aid website.
|
Pre-consultation, 1 week after baseline (T2), Initial post-consultation, within 48 hours of urology visit (T3)
|
|
Mean Shared Decision Making Questionnaire Score
Time Frame: Initial post-consultation, within 48 hours of urology visit (T3)
|
The Shared Decision Making Questionnaire measures the decisional process in medical encounters from both the patient and the physician perspectives.
The questionnaire contains 9 questions with answers on a 6-point Likert scale.
Scores range from 0-100 with higher scores indicating a higher perceived level of shared decision making.
|
Initial post-consultation, within 48 hours of urology visit (T3)
|
|
Mean Preparation for Decision Making Score
Time Frame: Pre-consultation, 1 week after baseline (T2)
|
The Preparation for Decision Making scale (Prep-DM) scale assesses a patient's perception of how useful a decision aid or other decision support intervention is in preparing the respondent to communicate with their practitioner at a consultation focused on making a health decision.
The scale contains 10 questions with answers on a Likert Scale Scores range from 0-100 with higher scores indicating a higher perceived level of preparation for decision making.
|
Pre-consultation, 1 week after baseline (T2)
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Katherine Hubert Chan, MD, MPH, University of North Carolina, Chapel Hill
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 21-0146
- K23DK111987 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypospadias
-
Ain Shams UniversityCompletedPediatric Anesthesia | Postoperative Analgesia | Hypospadias RepairEgypt
-
Assiut UniversityNot yet recruiting
-
dr. Muhammad Abdelhafez Mahmoud, MDCompletedChordee | Hypospadias, Penoscrotal
-
Sohag UniversityCompletedCosmotic Outcome of Distal Penile Hypospidias Repair Using Stitch by Stitch Glanuloplasty Versus TIPDistal Penile HypospadiasEgypt
-
Yonsei UniversityCompletedPediatric Patients Undergoing Hypospadias SurgeryKorea, Republic of
-
Tanta UniversityUnknownPediatric | Dexmedetomidine Infusion | Hypospadias Repair SurgeryEgypt
-
Isfahan University of Medical SciencesUnknown
-
Nemours Children's ClinicCompletedHypospadias and EpispadiasUnited States
-
Sir Ganga Ram HospitalCompletedDistal HypospadiasIndia
Clinical Trials on Decision Aid Website
-
Jamie StudtsUniversity of MiamiCompletedLung NeoplasmsUnited States
-
University of Texas at AustinWashington University School of Medicine; Ohio State UniversityCompletedStage I Breast Cancer | Stage II Breast Cancer | Breast Cancer Female | Ductal Carcinoma in Situ | Lobular Breast Carcinoma | Stage III Breast Cancer | Ductal Breast CarcinomaUnited States
-
Universidade do PortoGeorgetown University; NOVA Medical SchoolUnknown
-
University of Colorado, DenverNational Institute on Aging (NIA)CompletedStroke | Multiple Sclerosis | Glaucoma | Brain Injuries | Macular Degeneration | Arthritis | Chronic Obstructive Pulmonary Disease | Parkinson Disease | Restless Legs Syndrome | Diabetic Retinopathy | Insomnia | Retinitis Pigmentosa | Obstructive Sleep Apnea | Dementia | End Stage Renal Disease | Sleep Apnea | Syncope | Seizures and other conditionsUnited States
-
Agency for Healthcare Research and Quality (AHRQ)Completed
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Active, not recruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic... and other conditionsUnited States
-
Montefiore Medical CenterCompletedContraceptionUnited States
-
University of LeedsBaxter Healthcare Corporation; National Health Service, United Kingdom; Foundation... and other collaboratorsCompletedChronic Kidney FailureUnited Kingdom
-
University Hospital HeidelbergInnovationsfonds des Gemeinsamen Bundesausschusses, GermanyCompletedPatient Decision Aid | Treatment As UsualGermany
-
Massachusetts General HospitalCompletedCoronary Artery Disease | Stable AnginaUnited States